FDA Inspection 746885 — Medefil Incorporated

Medefil Incorporated — FEI 3001677091

The FDA completed an inspection of Medefil Incorporated on September 6, 2011 in Glendale Heights, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 6, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Glendale Heights, IL (United States)